ES2049712T1 - Un metodo para producir una composicion farmaceutica. - Google Patents

Un metodo para producir una composicion farmaceutica.

Info

Publication number
ES2049712T1
ES2049712T1 ES93300520T ES93300520T ES2049712T1 ES 2049712 T1 ES2049712 T1 ES 2049712T1 ES 93300520 T ES93300520 T ES 93300520T ES 93300520 T ES93300520 T ES 93300520T ES 2049712 T1 ES2049712 T1 ES 2049712T1
Authority
ES
Spain
Prior art keywords
rent
hydrogen
fenyl
alcoxy
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES93300520T
Other languages
English (en)
Inventor
Shiro Mita
Yoichi Kawashima
Ken-Ichi Fujimura
Hiroshi Suhara
Masahiro Okamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of ES2049712T1 publication Critical patent/ES2049712T1/es
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)

Abstract

UN COMPUESTO DE LA FORMULA [I] O UNA SAL ACEPTABLE FARMACEUTICAMENTE, DONDE R1 Y R2 SON IGUALES O DIFERENTES Y CADA UNO DE ELLOS ES HIDROGENO O ALQUIL INFERIOR; R3 Y R4 SON IGUALES O DIFERENTES Y CADA UNO DE ELLOS ES HIDROGENO, ALQUIL INFERIOR, CARBOXI O ALCOXICARBONIL INFERIOR; R5 ES HIDROGENO O ALQUIL INFERIOR; X ES OXIGENO O NR6; R6 ES HIDROGENO, ALQUIL INFERIOR, ALCOXI INFERIOR, ALQUIL INFERIOR FENIL O ALCOXI INFERIOR FENIL, Y EL ALQUIL INFERIOR MENCIONADO PUEDE SER SUSTITUIDO MEDIANTE GRUPOS CARBOXI, ALCOXICARBONIL INFERIOR, AMINO, ALQUILAMINO INFERIOR, ALCOXICARBONILAMINO INFERIOR O ALQUILAMINO INFERIOR FENIL, Y EL ANILLO FENIL DEL ALQUIL INFERIOR FENIL MENCIONADO, ALCOXI INFERIOR FENIL O ALQUILAMINO INFERIOR FENIL PUEDE SER SUSTITUIDO POR ALQUIL INFERIOR, ALCOXI INFERIOR, HALOGENO, CARBOXI O ALCOXICARBONIL INFERIOR; A ES ALQUILENO INFERIOR DE CADENA RECTA O RAMIFICADA, N ES 0 O 1. TALES COMPUESTOS SON UTILIZABLES PARA EL TRATAMIENTO DE ENFERMEDADES DIVERSAS ORIGINADAS POR DESORDENESDE INMUNIZACION TALES COMO INMUNODEFICIENCIA Y ENFERMEDADES AUTOINMUNES.
ES93300520T 1992-01-31 1993-01-25 Un metodo para producir una composicion farmaceutica. Pending ES2049712T1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4060887A JP2906236B2 (ja) 1992-01-31 1992-01-31 ビシクロ化合物

Publications (1)

Publication Number Publication Date
ES2049712T1 true ES2049712T1 (es) 1994-05-01

Family

ID=13155329

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93300520T Pending ES2049712T1 (es) 1992-01-31 1993-01-25 Un metodo para producir una composicion farmaceutica.

Country Status (6)

Country Link
US (1) US5350860A (es)
EP (1) EP0554032B1 (es)
JP (1) JP2906236B2 (es)
DE (2) DE69326173T2 (es)
ES (1) ES2049712T1 (es)
GR (1) GR940300002T1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0639566B1 (en) * 1991-01-10 2001-06-20 Santen Pharmaceutical Co., Ltd. Cyclic compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6058973A (ja) * 1983-09-13 1985-04-05 Mitsubishi Yuka Yakuhin Kk γ−プチロラクトン誘導体及びそれを有効成分とする免疫調節剤
EP0639566B1 (en) * 1991-01-10 2001-06-20 Santen Pharmaceutical Co., Ltd. Cyclic compound

Also Published As

Publication number Publication date
US5350860A (en) 1994-09-27
JP2906236B2 (ja) 1999-06-14
DE69326173T2 (de) 2000-03-09
EP0554032A2 (en) 1993-08-04
GR940300002T1 (es) 1994-02-28
DE554032T1 (de) 1994-02-24
DE69326173D1 (de) 1999-10-07
EP0554032B1 (en) 1999-09-01
JPH05213961A (ja) 1993-08-24
EP0554032A3 (en) 1993-08-18

Similar Documents

Publication Publication Date Title
ATE121389T1 (de) Ringverknüpfte analoge von stickstoffenthaltenden nichtaromatischen heterocyclen.
ATE61581T1 (de) Chemische verbindungen.
DE69616480D1 (de) Piperidinderivate als neurokininantagonisten
ES2060020T3 (es) Derivados de pirrolidina.
YU40300A (sh) Aril fuzirana azapoliciklična jedinjenja
PE34297A1 (es) Ligandos especificos del neuropeptido y1
MY116002A (en) Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis
PE106499A1 (es) Antagonistas del receptor ccr-3
ATE255635T1 (de) Polypeptid, fähig zur inhibierung der bindung zwischen menschliches il-6 und dessen rezeptor
CA2036304A1 (en) Pyrimidinedione derivatives, their production and use
EA199700117A1 (ru) Трициклические бензазепиновые антагонисты вазопрессина, способ их получения, фармацевтическая композиция и способ лечения млекопитающих с использованием трициклических бензазепинов
DE69414554D1 (de) Heterocyclische verbindungen und ihre herstellung und verwendung
DE69510928D1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung
BG101947A (en) Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
SE9702564D0 (sv) New compounds
DK0544714T3 (da) Heterocycliske forbindelser og fremstilling og anvendelse deraf
MX9302475A (es) Polipeptido de origen no natural que tiene la actividad del factor recombinante de estimulacion del receptor neu y proceso para la produccion del mis mo.
HU907025D0 (en) Process for producing substituted n-(imidazolyl-alkyl)-alanine derivatives and pharmaceutical preparatives containing these compounds as active substance
ES2032570T3 (es) Derivados antiparkinson de ergolina. (reserva del art. 167.2 cpe).
ATE254121T1 (de) Heterocyclische verbindungen als bradykinin antagonisten
HUP0003078A2 (hu) 5-HT3 és 5-HT4 receptorok által közvetített betegségek kezelésére alkalmazható (+)-norciszaprid
ES2136291T3 (es) Derivados de pirimidina.
DE69409796D1 (de) Neue verwendung bis-heterocyclische verbindungen und dessen zusammensetzungen
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
ES2049712T1 (es) Un metodo para producir una composicion farmaceutica.